WuXi AppTec Co., Ltd. (603259.SS)
CNY 56.05
(-0.09%)
CNY 56.05
(-0.09%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 40.04 Billion CNY | 1.75% |
| 2022 | 39.35 Billion CNY | 71.84% |
| 2021 | 22.9 Billion CNY | 38.5% |
| 2020 | 16.53 Billion CNY | 28.46% |
| 2019 | 12.87 Billion CNY | 33.89% |
| 2018 | 9.61 Billion CNY | 23.8% |
| 2017 | 7.76 Billion CNY | 26.96% |
| 2016 | 6.11 Billion CNY | 25.24% |
| 2015 | 4.88 Billion CNY | 17.96% |
| 2014 | 4.13 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 9.18 Billion CNY | 15.02% |
| 2024 Q3 | 10.46 Billion CNY | 13.95% |
| 2024 Q1 | 7.98 Billion CNY | -25.25% |
| 2023 FY | 40.04 Billion CNY | 1.75% |
| 2023 Q4 | 10.67 Billion CNY | 0.07% |
| 2023 Q3 | 10.67 Billion CNY | 7.7% |
| 2023 Q1 | 8.96 Billion CNY | -18.22% |
| 2023 Q2 | 9.9 Billion CNY | 10.53% |
| 2022 Q2 | 9.28 Billion CNY | 9.53% |
| 2022 FY | 39.35 Billion CNY | 71.84% |
| 2022 Q4 | 10.96 Billion CNY | 3.03% |
| 2022 Q3 | 10.63 Billion CNY | 14.61% |
| 2022 Q1 | 8.47 Billion CNY | 32.81% |
| 2021 Q4 | 6.38 Billion CNY | 6.62% |
| 2021 FY | 22.9 Billion CNY | 38.5% |
| 2021 Q3 | 5.98 Billion CNY | 7.14% |
| 2021 Q2 | 5.58 Billion CNY | 12.84% |
| 2021 Q1 | 4.95 Billion CNY | 4.87% |
| 2020 Q2 | 4.04 Billion CNY | 26.87% |
| 2020 Q1 | 3.18 Billion CNY | -11.3% |
| 2020 FY | 16.53 Billion CNY | 28.46% |
| 2020 Q4 | 4.72 Billion CNY | 2.99% |
| 2020 Q3 | 4.58 Billion CNY | 13.34% |
| 2019 Q1 | 2.76 Billion CNY | 2.86% |
| 2019 FY | 12.87 Billion CNY | 33.89% |
| 2019 Q4 | 3.59 Billion CNY | 6.19% |
| 2019 Q3 | 3.38 Billion CNY | 8.3% |
| 2019 Q2 | 3.12 Billion CNY | 12.83% |
| 2018 Q3 | 2.51 Billion CNY | 10.78% |
| 2018 Q1 | 2.14 Billion CNY | 2.61% |
| 2018 Q2 | 2.26 Billion CNY | 5.87% |
| 2018 FY | 9.61 Billion CNY | 23.8% |
| 2018 Q4 | 2.69 Billion CNY | 7.19% |
| 2017 Q3 | 2.01 Billion CNY | 6.08% |
| 2017 Q1 | 1.76 Billion CNY | 0.0% |
| 2017 FY | 7.76 Billion CNY | 26.96% |
| 2017 Q4 | 2.08 Billion CNY | 3.72% |
| 2017 Q2 | 1.89 Billion CNY | 7.3% |
| 2016 FY | 6.11 Billion CNY | 25.24% |
| 2015 FY | 4.88 Billion CNY | 17.96% |
| 2014 FY | 4.13 Billion CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 9.14 Billion CNY | -337.758% |
| Joinn Laboratories(China)Co.,Ltd. | 2.37 Billion CNY | -1584.98% |
| Autobio Diagnostics Co., Ltd. | 4.44 Billion CNY | -801.135% |
| Thalys Medical Technology Group Inc. | 2 Billion CNY | -1896.044% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 8.53 Billion CNY | -368.912% |
| Chemclin Diagnostics Co., Ltd. | 445.34 Million CNY | -8891.614% |